Harnessing NKG2D CAR-T cells with radiotherapy: a novel approach for esophageal squamous cell carcinoma treatment
BackgroundEsophageal squamous cell carcinoma (ESCC) represents a highly aggressive malignancy with poor prognosis and limited therapeutic advancements. While chimeric antigen receptor (CAR)-T-cell therapy has revolutionized cancer treatment, its application in ESCC remains poorly explored. This stud...
Saved in:
| Main Authors: | Tianyu Liu, Liyuan Fan, Weicheng Huang, Pengxiang Chen, Yuchen Liu, Shuyun Wang, Kaiyue Guo, Yufeng Cheng, Yali Han |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1589379/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An anoikis-related signature predicts prognosis and immunotherapy response in gastrointestinal cancers
by: Ruyi Liu, et al.
Published: (2025-02-01) -
Sodium valproate enhances efficacy of NKG2D CAR-T cells against glioblastoma
by: Junchen Liu, et al.
Published: (2025-01-01) -
Romidepsin Enhances the Killing Ability of NKG2D-CAR-T Cells through Enhanced Expression of NKG2DL against Ovarian Cancer Cells
by: Liang Wang, et al.
Published: (2022-09-01) -
CAR-T cells dual-target CD123 and NKG2DLs to eradicate AML cells and selectively target immunosuppressive cells
by: Xin Jin, et al.
Published: (2023-12-01) -
A Concise Review of the Role of the NKG2D Receptor and Its Ligands in Cancer
by: Elitsa Boneva, et al.
Published: (2025-03-01)